4.5 Article

Simultaneous/Incidental Cholecystectomy During Gastric/Esophageal Resection: Systematic Analysis of Risks and Benefits

期刊

WORLD JOURNAL OF SURGERY
卷 34, 期 5, 页码 1008-1014

出版社

SPRINGER
DOI: 10.1007/s00268-010-0444-1

关键词

-

类别

向作者/读者索取更多资源

After esophageal/gastric resection with resulting truncal vagotomy, the incidence of gallstone formation seems to increase. The clinical relevance of gallstones and the role of simultaneous/incidental cholecystectomy in this setting are controversially discussed. Systematic analysis has been performed for retrospective/prospective studies on the incidence/symptoms of gallstone formation after esophageal/gastric resection. Pooled estimates of the incidence of cholecystectomies were calculated by random effect models. Risk analyses of simultaneous, acute postoperative cholecystectomy and long-term cholecystectomy were performed. Sixteen studies on gallstone formation after upper gastrointestinal (GI) surgery (3,735 patients) reported increased incidences of 5-60% with a pooled estimate of 17.5% (95% confidence interval (CI), 14.1-21.2%; inconsistency statistic (I (2)) = 86%) compared with 4-12% in the control population. In 113 of 3,011 patients (12 studies), late cholecystectomies were performed for symptomatic cholecystolithiasis, corresponding to an estimated overall proportion of 4.7% (95% CI, 2.1-8.2%; I (2) = 92%). In 1.2% (95% CI, > 0-3.7%; I (2) = 93%) of patients undergoing upper GI surgery, a cholecystectomy was performed because of acute postoperative biliary problems (4 studies, 8,748 patients). Simultaneous cholecystectomy had a higher morbidity of 0.95% (95% CI, 0.54-1.49%; I (2) = 28%) compared with the calculated additional morbidity of early and late cholecystectomy of 0.45%. Approximately 6% of patients undergoing upper GI surgery are expected to require cholecystectomy during follow-up. Because late cholecystectomies can be performed safely and because the additional calculated morbidity for these operations is lower than the morbidity for simultaneous cholecystectomy, it cannot generally be recommended to remove a normal acalculous gallbladder during upper GI surgery.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Oncology

Targeting and Reprograming Cancer-Associated Fibroblasts and the Tumor Microenvironment in Pancreatic Cancer

Yoshiaki Sunami, Viktoria Boeker, Joerg Kleeff

Summary: Targeting cancer-associated fibroblasts has been considered a promising therapeutic strategy for pancreatic cancer, yet depleting these cells may have tumor-promoting effects due to their functional heterogeneity. It is therefore important to selectively target the tumor-promoting subtype of cancer-associated fibroblasts to achieve effective treatment outcomes.

CANCERS (2021)

Review Oncology

Management problems in patients with pancreatic cancer from a surgeon's perspective

Johannes Klose, Ulrich Ronellenfitsch, Joerg Kleeff

Summary: Pancreatic cancer is a deadly gastrointestinal tumor, with surgery being the only chance for cure. This review article discusses the surgical management of pancreatic cancer-related problems and treatment options for unresectable, metastasized, and recurring cases, including potential resection of oligometastatic disease in certain situations.

SEMINARS IN ONCOLOGY (2021)

Article Surgery

Early Drain Removal is Safe in Patients With Low or Intermediate Risk of Pancreatic Fistula After Pancreaticoduodenectomy A Multicenter, Randomized Controlled Trial

Menghua Dai, Qiaofei Liu, Cheng Xing, Xiaodong Tian, Feng Cao, Wenbo Tang, Shaocheng Lv, Yongsu Ma, Dongxin Zhang, Jorg Kleeff, Yinmo Yang, Rong Liu, Qiang He, Fei Li, Guangming Li, Junchao Guo, Quan Liao, Yupei Zhao

Summary: The study found that early drain removal did not significantly decrease the incidence of grade 2-4 complications for patients undergoing pancreaticoduodenectomy with low or intermediate risk. There were no significant differences between the two groups in terms of comprehensive complication index, B/C grade pancreatic fistula incidence, total medical expenses, and postoperative in-hospital stay.

ANNALS OF SURGERY (2022)

Article Gastroenterology & Hepatology

AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53

Zhiheng Zhang, Hongzhen Li, Yibin Deng, Kathleen Schuck, Susanne Raulefs, Nadja Maeritz, Yuanyuan Yu, Torsten Hechler, Andreas Pahl, Vanesa Fernandez-Saiz, Yuan Wan, Guosheng Wang, Thomas Engleitner, Rupert Oellinger, Roland Rad, Maximilian Reichert, Kalliope N. Diakopoulos, Verena Weber, Jingjing Li, Shanshan Shen, Xiaoping Zou, Joerg Kleeff, Andre Mihaljevic, Christoph W. Michalski, Hana Alguel, Helmut Friess, Bo Kong

Summary: The study demonstrates that Agr2 is up-regulated during the ADM-to-pancreatic intraepithelial neoplasia transition in the context of inflammation and Kras(G12D) -driven early pancreatic carcinogenesis. Genetic ablation of Agr2 blocks the metaplastic-to-neoplastic process by interfering with the nuclear import of RNAPII. The developed hexapeptide disrupts the Agr2-RNAPII complex, leading to dysfunction of RNAPII and compromised initiation of PDAC.

GASTROENTEROLOGY (2021)

Article Surgery

The in situ near-total pancreatectomy (LIVOCADO procedure) for end-staged chronic pancreatitis

Ryan D. Baron, Andrea R. G. Sheel, Ammad Farooq, Joerg Kleeff, Pietro Contin, Christopher M. Halloran, John P. Neoptolemos

Summary: The Livocado procedure is a safe and successful option for patients with chronic pancreatitis complicated by vascular involvement. Post-operative pain scores significantly improved, with two-thirds of patients being completely pain-free at 12 months, and employment rehabilitation rates also increased significantly.

LANGENBECKS ARCHIVES OF SURGERY (2021)

Article Biochemistry & Molecular Biology

Identification of prognostic lipid droplet-associated genes in pancreatic cancer patients via bioinformatics analysis

Rubing Bai, Artur Rebelo, Jorg Kleeff, Yoshiaki Sunami

Summary: Pancreatic cancer is a significant cause of death in the United States, with lipid droplet-associated genes playing a crucial role in the prognosis of pancreatic cancer. Among these genes, CAV2 stands out as the only independent prognostic factor.

LIPIDS IN HEALTH AND DISEASE (2021)

Editorial Material Gastroenterology & Hepatology

Intracystic Papillary Neoplasm of the Gallbladder

Niels Michael Doerr, Ingmar Kaden, Joerg Kleeff

JOURNAL OF GASTROINTESTINAL SURGERY (2022)

Review Oncology

Cancer-Associated Fibroblasts and Tumor Cells in Pancreatic Cancer Microenvironment and Metastasis: Paracrine Regulators, Reciprocation and Exosomes

Yoshiaki Sunami, Johanna Haeussler, Anais Zourelidis, Joerg Kleeff

Summary: Cancer-associated fibroblasts play a crucial role in the tumor microenvironment, communicating with tumor cells through paracrine and exosome-mediated signaling to regulate cancer progression, invasion, and metastasis.

CANCERS (2022)

Review Health Care Sciences & Services

Lymph Node Yield in Gastrointestinal Cancer Surgery With or Without Prior Neoadjuvant Therapy: Protocol for a Systematic Review and Meta-analysis

Ulrich Ronellenfitsch, Nika Mathis, Juliane Friedrichs, Joerg Kleeff

Summary: This study aims to summarize the available evidence regarding the lymph node yield in patients with gastrointestinal carcinomas undergoing surgery after neoadjuvant therapy compared to those undergoing surgery without neoadjuvant therapy. The findings of the meta-analysis will determine if neoadjuvant therapy affects the lymph node yield.

JMIR RESEARCH PROTOCOLS (2022)

Article Cell Biology

Single Cell Analysis of Cultivated Fibroblasts from Chronic Pancreatitis and Pancreatic Cancer Patients

Yoshiaki Sunami, Yijun Chen, Bogusz Trojanowicz, Matthias Sommerer, Monika Haemmerle, Roland Eils, Joerg Kleeff

Summary: Cancer-associated fibroblasts (CAFs) have been found to play a major role in the progression and drug resistance of pancreatic cancer. This study used single-cell RNA sequencing (scRNA-seq) and bioinformatics analysis to compare CAFs/DAFs from both chronic pancreatitis and pancreatic cancer patients. The results showed that CAFs/DAFs in both conditions exhibit similar phenotypes, and cell cycle-related genes play an important role in both pancreatic cancer and chronic pancreatitis, suggesting common mechanisms underlying both diseases.
Article Medicine, General & Internal

Single-Center Retrospective Subgroup Analysis of Primary Aortic (Aneurysm, Aortic Dissection, PAU) and Secondary Aortic (Iatrogenic, Trauma, Aortoesophageal Fistula) Indications for Emergency TEVAR

Artur Rebelo, Jumber Partsakhashvili, Ulrich Ronellenfitsch, Endres John, Joerg Kleeff, Joerg Ukkat

Summary: This study analyzed the outcome of emergency thoracic endovascular aortic repair (TEVAR) in the treatment of primary and secondary aortic pathologies. The results showed that in-hospital mortality and morbidity were still considerable after emergency TEVAR. Pre- and postoperative levels of hemoglobin, creatinine, and lactate may be valuable in predicting patient outcomes.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Health Care Sciences & Services

Fibroblast Activation Protein Overexpression in Gastrointestinal Tumors: Protocol for a Systematic Review and Meta-analysis

Yoshiaki Sunami, Ulrich Ronellenfitsch, Jorg Kleeff, Artur Rebelo

Summary: This study aims to evaluate the impact of FAP expression on survival and clinical characteristics in gastrointestinal tumors. A systematic review and meta-analysis will be conducted to compare patients with and without FAP overexpression in terms of postoperative survival, histological differentiation, tumor invasion, lymph node metastases, and distant metastases. The expected results will provide new evidence on the prognostic value of FAP in gastrointestinal tumors.

JMIR RESEARCH PROTOCOLS (2023)

Review Oncology

Cholesterol Metabolism in Pancreatic Cancer

Artur Rebelo, Joerg Kleeff, Yoshiaki Sunami

Summary: This review provides an in-depth understanding of metabolic reprogramming and the mevalonate pathway in pancreatic cancer. It emphasizes the role of cholesterol metabolism in cancer progression and explores potential therapeutic approaches targeting these processes. The review also highlights promising pharmaceutical candidates for pancreatic cancer therapy.

CANCERS (2023)

Article Surgery

Pancreatoduodenectomy with or without prophylactic falciform ligament wrap around the hepatic artery for prevention of postpancreatectomy haemorrhage: randomized clinical trial (PANDA trial)

Thilo Welsch, Benjamin Muessle, Sandra Korn, Dorothee Sturm, Ulrich Bork, Marius Distler, Xina Graehlert, Anna Klimova, Nicole Trebesius, Axel Kleespies, Stefan Kees, Stefan Beckert, Daniel Reim, Helmut Friess, Malik Elwerr, Joerg Kleeff, Octavian Popescu, Hubertus Schmitz-Winnenthal, Monika Janot-Matuschek, Waldemar Uhl, Georg F. Weber, Maximilian Brunner, Henriette Golcher, Robert Gruetzmann, Juergen Weitz

Summary: This study suggests that a prophylactic falciform ligament wrap may be effective in preventing postpancreatectomy haemorrhage from the hepatic artery or gastroduodenal artery stump.

BRITISH JOURNAL OF SURGERY (2022)

Article Oncology

The impact of atezolizumab and bevacizumab in hepatocellular carcinoma with activated ss-catenin signaling

Sebastian Krug, Laura Mattheis, Monika Haemmerle, Jonas Rosendahl, Joerg Kleeff, Patrick Michl

Summary: Patients with Wnt/ss-β-catenin activation may benefit from combination therapy with atezolizumab and bevacizumab regardless of potential predictive markers for immune checkpoint inhibition.

CANCER REPORTS (2022)

暂无数据